Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
…, T Chiba, M Mishima, T Hibi, H Tsubouchi… - Modern …, 2012 - Taylor & Francis
IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. …
serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. …
Evidence for the identity of human scatter factor and human hepatocyte growth factor.
…, H Rieder, C Fonatsch, H Tsubouchi… - Proceedings of the …, 1991 - National Acad Sciences
Scatter factor (SF), a secretory protein of fibroblasts, dissociates and increases the motility of
epithelial cells and may be involved in cell migration processes during embryogenesis and …
epithelial cells and may be involved in cell migration processes during embryogenesis and …
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor
K Miyazawa, H Tsubouchi, D Naka, K Takahashi… - Biochemical and …, 1989 - Elsevier
Amino acid sequences of four peptide fragments of human hepatocyte growth factor purified
from the plasma of patients with fulminant hepatic failure were determined. Based on the …
from the plasma of patients with fulminant hepatic failure were determined. Based on the …
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
…, H Kumada, N Hayashi, S Kaneko, H Tsubouchi… - European journal of …, 2011 - Elsevier
BACKGROUND: In Japan and South Korea, transarterial chemoembolisation (TACE) is an
important locoregional treatment for patients with unresectable hepatocellular carcinoma (…
important locoregional treatment for patients with unresectable hepatocellular carcinoma (…
Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012
H Ohara, K Okazaki, H Tsubouchi, K Inui… - Journal of hepato-biliary …, 2012 - Springer
Background IgG4-sclerosing cholangitis (IgG4-SC) patients have an increased level of serum
IgG4, dense infiltration of IgG4-positive plasma cells with extensive fibrosis in the bile duct …
IgG4, dense infiltration of IgG4-positive plasma cells with extensive fibrosis in the bile duct …
[HTML][HTML] Evidence-based clinical practice guidelines for liver cirrhosis 2015
…, M Seike, S Nagoshi, M Segawa, H Tsubouchi… - Journal of …, 2016 - Springer
The Japanese Society of Gastroenterology revised the evidence-based clinical practice
guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected, and a …
guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected, and a …
[HTML][HTML] Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
…, I Sakaida, M Nakamuta, T Mizuta, H Tsubouchi… - Journal of …, 2015 - Springer
Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic
liver disease in industrialized countries worldwide, and has become a serious public health …
liver disease in industrialized countries worldwide, and has become a serious public health …
[PDF][PDF] Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population
…, Y Maehara, S Uemoto, N Kokudo, H Tsubouchi… - The American Journal of …, 2012 - cell.com
For the identification of susceptibility loci for primary biliary cirrhosis (PBC), a genome-wide
association study (GWAS) was performed in 963 Japanese individuals (487 PBC cases and …
association study (GWAS) was performed in 963 Japanese individuals (487 PBC cases and …
BCAA-enriched snack improves nutritional state of cirrhosis
…, H Okuda, M Onji, H Kanazawa, H Tsubouchi… - Nutrition, 2007 - Elsevier
OBJECTIVE: A late evening snack improves the catabolic state in patients with advanced
liver cirrhosis. We tested whether long-term (3 mo) late evening snacking that included a …
liver cirrhosis. We tested whether long-term (3 mo) late evening snacking that included a …
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
…, J Toyota, T Okanoue, K Chayama, H Tsubouchi… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: To evaluate the efficacy and safety of telaprevir in combination
with peginterferon-α2b (PEG-IFN) and ribavirin (RBV) in patients with chronic hepatitis C. …
with peginterferon-α2b (PEG-IFN) and ribavirin (RBV) in patients with chronic hepatitis C. …